Exploring the Link Between Oral Health and Cardiovascular Disease
Tamara Horwich, MD, Eugenia Gianos, MD, and Kenneth Fleisher, DDS, reflect on the link between cardiovascular disease and oral health.
Tamara Horwich, MD, Eugenia Gianos, MD, and Kenneth Fleisher, DDS, reflect on the link between cardiovascular disease and oral health.
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
A look into the growing number of cases of stress cardiomyopathy, also known as Takotsubo syndrome, that have been observed during the COVID-19 pandemic.
What are the most effective pharmacologic therapies recommended for treating patients with moderate to severe COVID-19? Drs Sarina Sahetya of Johns Hopkins University, Matthew Exline of Ohio State University, and Minjoung Go of Stanford University offer their perspectives.
Elizabeth Profita, MD, and Gerard J. Boyle, MD, FACC, discuss myocarditis in younger populations and how pediatric cardiologists should respond with treatment.
Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
Katy Leung, MD, provides insight into the existing sex and gender differences between men and women with axial spondyloarthritis.
A significant number of cases of post-COVID-19 myocarditis have been reported.
Recommendations for clinicians regarding the treatment of skin infections in people who inject drugs was provided in an interview with Raja Sivamani, MD, MS, AP.
Drs Kronzer and Tatangelo discuss the major comorbidities of patients before and after the diagnosis of rheumatoid arthritis and how to manage these disorders.